UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031982
Receipt number R000036509
Scientific Title The effect of bronchial thermoplasty on severe asthmatic cough.
Date of disclosure of the study information 2018/05/01
Last modified on 2022/04/04 21:51:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of bronchial thermoplasty on severe asthmatic cough.

Acronym

The effect of BT on severe asthmatic cough

Scientific Title

The effect of bronchial thermoplasty on severe asthmatic cough.

Scientific Title:Acronym

The effect of BT on severe asthmatic cough

Region

Japan


Condition

Condition

Severe classical asthma, severe cough-predominant asthma, and severe cough-variant asthma

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the effect of bronchial thermoplasty on severe asthmatic cough.

Basic objectives2

Others

Basic objectives -Others

To investigate the mechanisms of bronchial thermoplasty on severe asthmatic cough.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The improvement of cough intensity and cough specific quality of life.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Bronchial thermoplasty will be performed at 3-week intervals.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Severe classical asthma, severe cough-predominant asthma, and severe cough-variant asthma whose asthma or cough control are poor irrespective of high dose inhaled corticosteroids (ICS).

Key exclusion criteria

Those who meet the contraindication criteria of bronchial thermoplasty.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Kanemitsu

Organization

Nagoya City University

Division name

Dept of Respiratory Medicine, Allergy and Clinical Immunology Graduate School of Medical Sciences

Zip code

4678601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan

TEL

0528538216

Email

kaney32@med.nagoya-cu.ac.jp


Public contact

Name of contact person

1st name Yoshihiro
Middle name
Last name Kanemitsu

Organization

Nagoya City University

Division name

Dept of Respiratory Medicine, Allergy and Clinical Immunology Graduate School of Medical Sciences

Zip code

4678601

Address

1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan

TEL

0528538216

Homepage URL


Email

kaney32@med.nagoya-cu.ac.jp


Sponsor or person

Institute

Naogya City University

Institute

Department

Personal name



Funding Source

Organization

Self-sustaining

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences,

Address

1 Kawasumi, Mizuho-Cho, Mizuho-Ku

Tel

0528538216

Email

kaney32@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 20 Day

Date of IRB

2018 Year 03 Month 19 Day

Anticipated trial start date

2018 Year 05 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 29 Day

Last modified on

2022 Year 04 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036509


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name